Skip to main content
Equibles
ACB logo

ACB · Aurora Cannabis Inc

Track ACB — free

Use ACB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.95 +0.06 (+1.54%) At close · Sep 4
Rebalance outlook locked
Market Cap
$244.41M
Shares
63.31M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.95 Open$3.89 Day$3.86–3.97 52W close$2.58–6.23 Avg vol 30d1.7M Short int7.3M · 11.5% float · 2.9d Short vol51% Last earningsAug 5, 2026 DataFeb 2024–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Feb 20, 2024; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 23, 2026 Est · unconfirmed · in 11 wks

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-18.2%
Trailing year
Short interest
11.5%
Latest settlement · 2.9 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +9%
above
Price vs 50-day avg +24%
above
RSI (14) 66
neutral
MACD trend Negative
52-week position 38%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +32%
trailing
6-month return +14%
trailing
YTD return −6%
this year
Relative strength −1%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +23 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
11.50% of float · ▼ -7.9% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
153 holders — near 3-yr low, contrarian setup
Squeeze score 66
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 64%
annualized · 1-yr
Max drawdown −59%
past year
ATR 3.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2021
by the first half of fiscal 2023
Annualized cost savings $150M – $170M
annualized basis
Cost savings $150M – $170M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+9% Bullish
Price vs 50-day avg
+24% Bullish
RSI (14)
66 Neutral
MACD trend
Negative Bearish
52-week position
38% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +23 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
11.50% of float · ▼ -7.9% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
153 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $3 Now $4 · 38% Range high $6
vs 200-day avg +9% vs 50-day avg +24%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ACB
Aurora Cannabis Inc
this stock
$244.41M -6.4% — — 11.5%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
 $66.37B — — — 0.0%
TAK
Takeda Pharmaceutical Co Ltd
 $59.75B +18.3% — — 0.1%
GALDY
Galderma Group AG/ADR
 $45.51B -5.8% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $42.67B +16.5% +4.3% 60.0 3.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
153
% held
10.1%
Net QoQ
-52.7K sh
Top holder
GOLDMAN SACHS GROUP INC
Held Float
View
Held by Funds
Fund positions
20
View
Short & Settlement
Short Interest Falling
Shares short
7.3M
Days to cover
2.9d
Change
-628.3K sh
View
Short Volume
Short vol %
51%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
7.3K
Value
$27.8K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
53.9%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
John A. Yarmuth
Amount
$1.0K–$15.0K
Traded
Feb 12, 2021
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 2, 2026
This year
33
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View

Performance

Raw-price comparisons begin at the captured split on Feb 20, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
ACB -1.5% +32.1% +14.5% -2.5% -6.4%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -1.6% +32.5% -0.6% -2.9% -19.3%
Key facts CIK 1683541 CUSIP 05156X850 13F (30d) 85 filings 85 filers Visit website